AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
A copy of the same can be downloaded here . In the quarter the fund returned 9.15% (net), compared to a 12.75% return for the Russell 2000 Growth Index. For the year, the fund returned 15.96% (net) compared to 18.66% for the index. In addition, please check the fund's top five holdings to know its best picks in 2023. TimesSquare Capital U.S. Small Cap Growth Strategy featured stocks like AtriCure, Inc. (NASDAQ: ATRC ) in its Q4 2023 investor letter. Headquartered in Mason, Ohio, AtriCure, Inc. (NASDAQ:ATRC) develops and manufactures devices for surgical ablation. On March 21, 2024, AtriCure, Inc. (NASDAQ:ATRC) stock closed at $29.73 per share. One-month return of AtriCure, Inc. (NASDAQ:ATRC) was -11.41%, and its shares lost 27.19% of their value over the last 52 weeks. AtriCure, Inc. (NASDAQ:ATRC) has a market capitalization of $1.415 billion. TimesSquare Capital U.S. Small Cap Growth Strategy stated the following regarding AtriCure, Inc. (NASDAQ:ATRC) in its fourth quarter 2023 i
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure upgraded at Oppenheimer on valuation [Seeking Alpha]Seeking Alpha
- AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.MarketBeat
- AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management [Yahoo! Finance]Yahoo! Finance
- AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management [Yahoo! Finance]Yahoo! Finance
- AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain ManagementBusiness Wire
ATRC
Earnings
- 2/15/24 - Beat
ATRC
Sec Filings
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEFA14A
- 4/3/24 - Form DEFA14A
- ATRC's page on the SEC website